Reply to Matthew Bultitude and Tim O'Brien's letter to the editor re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009;56:903-10 Journal Article
| Author: | Dalbagni, G. |
| Article Title: | Reply to Matthew Bultitude and Tim O'Brien's letter to the editor re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009;56:903-10 |
| Keywords: | adult; cancer survival; controlled study; aged; surgical technique; major clinical study; cancer recurrence; cancer staging; outcome assessment; follow up; cancer diagnosis; cancer incidence; letter; bcg vaccine; clinical assessment; surgical approach; bladder cancer; cancer mortality; carcinoma in situ; cystectomy; transitional cell carcinoma |
| Journal Title: | European Urology |
| Volume: | 57 |
| Issue: | 4 |
| ISSN: | 0302-2838 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2010-04-01 |
| Start Page: | e41 |
| End Page: | e42 |
| Language: | English |
| DOI: | 10.1016/j.eururo.2010.01.018 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "CODEN: EUURA" - "Source: Scopus" |
